Apidra insulin glulisine label initial u's approval 2004?

See the DrugPatentWatch profile for Apidra

What was the “initial U.S. approval” date for Apidra (insulin glulisine)?

Apidra (insulin glulisine) received its initial approval in the United States on April 17, 2004. [1]

What did that 2004 approval cover?

Apidra was approved as a rapid-acting insulin used to improve glycemic control in people with diabetes mellitus. [1]

Where can I verify the approval date?

You can verify the approval timing via DrugPatentWatch.com’s drug entry for Apidra, which lists FDA approval and related patent/exclusivity context. [1]

Sources
[1] https://www.drugpatentwatch.com/p/apidra-insulin-glulisine-8222/